| Signatures of mutational processes in human cancer LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ... Nature 500 (7463), 415, 2013 | 4588 | 2013 |
| Clinical features and outcome of patients with non–small-cell lung cancer who harbor EML4-ALK AT Shaw, BY Yeap, M Mino-Kenudson, SR Digumarthy, DB Costa, ... Journal of clinical oncology 27 (26), 4247, 2009 | 1858 | 2009 |
| COSMIC: exploring the world's knowledge of somatic mutations in human cancer SA Forbes, D Beare, P Gunasekaran, K Leung, N Bindal, H Boutselakis, ... Nucleic acids research 43 (D1), D805-D811, 2014 | 1848 | 2014 |
| Systematic identification of genomic markers of drug sensitivity in cancer cells MJ Garnett, EJ Edelman, SJ Heidorn, CD Greenman, A Dastur, KW Lau, ... Nature 483 (7391), 570, 2012 | 1642 | 2012 |
| A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations SV Sharma, DY Lee, B Li, MP Quinlan, F Takahashi, S Maheswaran, ... Cell 141 (1), 69-80, 2010 | 1517 | 2010 |
| Prospective derivation of a living organoid biobank of colorectal cancer patients M van de Wetering, HE Francies, JM Francis, G Bounova, F Iorio, A Pronk, ... Cell 161 (4), 933-945, 2015 | 712 | 2015 |
| The evolutionary history of lethal metastatic prostate cancer G Gundem, P Van Loo, B Kremeyer, LB Alexandrov, JMC Tubio, ... Nature 520 (7547), 353, 2015 | 690 | 2015 |
| Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells W Yang, J Soares, P Greninger, EJ Edelman, H Lightfoot, S Forbes, ... Nucleic acids research 41 (D1), D955-D961, 2012 | 659 | 2012 |
| A landscape of pharmacogenomic interactions in cancer F Iorio, TA Knijnenburg, DJ Vis, GR Bignell, MP Menden, M Schubert, ... Cell 166 (3), 740-754, 2016 | 513 | 2016 |
| Elevated CRAF as a potential mechanism of acquired resistance to BRAF inhibition in melanoma C Montagut, SV Sharma, T Shioda, U McDermott, M Ulman, LE Ulkus, ... Cancer research 68 (12), 4853-4861, 2008 | 487 | 2008 |
| Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors U McDermott, AJ Iafrate, NS Gray, T Shioda, M Classon, S Maheswaran, ... Cancer research 68 (9), 3389-3395, 2008 | 439 | 2008 |
| Targeting MYCN in neuroblastoma by BET bromodomain inhibition A Puissant, SM Frumm, G Alexe, CF Bassil, J Qi, YH Chanthery, ... Cancer discovery 3 (3), 308-323, 2013 | 406 | 2013 |
| MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling S Huang, M Hölzel, T Knijnenburg, A Schlicker, P Roepman, U McDermott, ... Cell 151 (5), 937-950, 2012 | 399* | 2012 |
| Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine D Dias‐Santagata, S Akhavanfard, SS David, K Vernovsky, G Kuhlmann, ... EMBO molecular medicine 2 (5), 146-158, 2010 | 351 | 2010 |
| Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling U McDermott, SV Sharma, L Dowell, P Greninger, C Montagut, J Lamb, ... Proceedings of the National Academy of Sciences 104 (50), 19936-19941, 2007 | 342 | 2007 |
| Genomics and the continuum of cancer care U McDermott, JR Downing, MR Stratton New England Journal of Medicine 364 (4), 340-350, 2011 | 306 | 2011 |
| Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue CS Cooper, R Eeles, DC Wedge, P Van Loo, G Gundem, LB Alexandrov, ... Nature genetics 47 (4), 367, 2015 | 266 | 2015 |
| Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma J Müller, O Krijgsman, J Tsoi, L Robert, W Hugo, C Song, X Kong, ... Nature communications 5, 5712, 2014 | 261 | 2014 |
| Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes JMC Tubio, Y Li, YS Ju, I Martincorena, SL Cooke, M Tojo, G Gundem, ... Science 345 (6196), 1251343, 2014 | 223 | 2014 |
| Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties MP Menden, F Iorio, M Garnett, U McDermott, CH Benes, PJ Ballester, ... PLoS one 8 (4), e61318, 2013 | 217 | 2013 |
